$235.0 Million
Asklepios BioPharmaceutical, Inc.
Asklepios BioPharmaceutical, Inc. received a Series A Preferred Equity investment from TPG Global, LLC and Vida Ventures, LLC for a minority stake
Financial Advisor
$58.5 Million
Respicardia, Inc.
Venture Debt
Financial Advisor
$100.0 Million
Recro Pharma, Inc.
Mezzanine Debt
Financial Advisor
ECG Management Consultants, Inc.
Unitranche Debt
Financial Advisor
$190.0 Million
Quilvest Capital Partners
Senior Term Loan
Sole Placement Agent
$81.3 Million
Trinity Biotech plc
Refinancing of Exchangeable Senior Notes and Repurchase Outstanding Exchangeable Senior Notes
Financial Advisor
$56.0 Million
Bridge to Life, Ltd.
Structured Capital Investment
Sole Placement Agent
$75.5 Million
Alliance Spine & Pain Centers
Senior Term Loan
Sole Placement Agent
Medbio Inc.
Senior Term Loan
Sole Placement Agent
$30.0 Million
AEGEA Medical Inc.
Senior Term Loan
Financial Advisor
Subscribe to Debt Capital Markets

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.